Back to mobile site

Ideaya Biosciences (IDYA) PT Raised to $53 at RBC Capital

April 14, 2026 6:39 AM EDT Send to a Friend
RBC Capital analyst Leonid Timashev raised the price target on Ideaya Biosciences (NASDAQ: IDYA) to $53.00 (from $49.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login